Nature retracts provocative PD-1 study that tied lung cancer survival to treatment timing
The reporting (5)
- Nature Retracts Cancer Study Suggesting Treatment Is Better Earlier in the Day MedPage Today · 44d ago
- Paolo Tarantino: Nature Medicine Retracts Debated Study on Early Morning Immunotherapy Benefits Oncodaily · 44d ago
- Nature Medicine retracts Chinese lung cancer immunotherapy timing study 747 Live · 44d ago
- Retraction of high-profile paper on cancer drug timing could hand ammo to China hawks Endpoints News · 44d ago
- Nature retracts provocative PD-1 study that tied lung cancer survival to treatment timing Fierce Pharma · 44d ago broke it first
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Related trends
Why cyclospora keeps showing up in produce season after season
Utah reports nearly 50 cyclosporiasis cases, prompting local farmers to emphasize the importance of local produce.
Everyone's talking about hormone therapy for menopause. Should I be on it?
Hormone replacement therapy use has nearly doubled since 2017 amid new guidelines and widespread public discussion.
FDA approves 1st mRNA flu shot, from Moderna
The first mRNA-based influenza vaccine has received federal approval in the United States.
DNR Closes Additional Areas of Cunningham Falls State Park Following Second Beaver Attack
Two separate beaver attacks at Cunningham Falls State Park prompt additional closures in Maryland.
GLP-1 Drugs May Have a Hidden Effect on Your Eyes, Study Finds
New safety guidance and a lawsuit spotlight a possible eye‑risk link in popular GLP-1 weight‑loss drugs.
Pesticide exposure linked to higher risk of ALS, research finds
New research links occupational pesticide exposure to a significantly heightened risk of motor neuron diseases like ALS.